SciELO - Scientific Electronic Library Online

 
vol.55 issue3Development and implementation of guidelines for quality assurance in breast cancer screening: The European experienceRetrospective analysis of Mexican National Addictions Survey, 2008: Bias identification and correction author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Salud Pública de México

Print version ISSN 0036-3634

Abstract

WIRTZ, Veronika J; DRESER, Anahí  and  HEREDIA-PI, Ileana. Challenges and opportunities for the development of a national pharmaceutical policy in México. Salud pública Méx [online]. 2013, vol.55, n.3, pp.329-336. ISSN 0036-3634.

Unlike many other Latin American countries Mexico has no coherent and explicit national pharmaceutical policy (NPP). Other national challenges are: high out-of-pocket expenditure on medicines despite the implementation of universal health care coverage through Seguro Popular, high prices of medicines in the private sector in comparison to other countries when adjusted for income level, and the lack of clear strategies to improve safety and efficiency in the use of medicines, in particular interventions aimed at private physicians, pharmacies and consumers. The aim of this paper is to describe the challenges and opportunities to (1) consolidate the processes of formulating, implementing and evaluating NPP, and (2) define the policy content with regard to access and use of medicines.

Keywords : medicines; drug utilization; policy making; pharmaceutical policy; Mexico.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )